Articles in topic: Pharmaceuticals and Biotechnology

Page 1

EMA Advisory Meeting on Clinical Trials 2026: New Rules

Marne-Cel FDA approval: gene therapy for LAD-I

Breakthrough technologies in oncology: shift to PROTAC and CAR-T

FDA rehabilitates HRT: end of menopause 'black box' warning

Renaming PCOS to PMOS: an $8 billion shift

Vepdegestrant: FDA approved the first PROTAC degrader

FDA to review CTx-1301 for ADHD treatment in children

Nutrition Shift: From Diets to Long-Term Body Support

FDA may approve ophthalmic bevacizumab Lytenava

Biosimilar without Phase 3: FDA and EMA Rewrite the Rules